Product Details:
| Brand Names | Xpreza, Vidaza, Onureg |
| Composition | Azacitidine |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Myelodysplastic syndromes, chronic myelomonocytic leukemia, acute myeloid leukemia (AML) |
| Strength | 200mg |
| Form | Tablet |
Product Name: Xpreza 200mg Tablet
Brand Names: Xpreza, Vidaza, Onureg
Composition: Azacitidine (200mg)
Manufacturer/Marketer: Natco Pharma Ltd
Packaging: To be provided (specify packaging details if available)
Treatment: Myelodysplastic syndromes, chronic myelomonocytic leukemia, acute myeloid leukemia (AML)
Product Description: Xpreza 200mg Tablet contains Azacitidine, a chemotherapy agent used to treat certain blood and bone marrow disorders such as myelodysplastic syndromes and acute myeloid leukemia. It works by restoring normal growth and maturation of blood cells and inhibiting cancerous cell proliferation
Product Details:
| Strength | 500 mg |
| Form | Tablet |
| Product Name | Bdron 500 Mg Tablets (Abiraterone Acetate 500mg) |
| Storage Condition | Dry Place |
| Manufactured By | BDR |
| Prescription/Non prescription | Prescription |
| Another Name | (Abiraterone Acetate 500mg) metastatic prostate cancer |
| Salt Name | (Abiraterone Acetate 500mg) |
Bdron 500 Tablet should not be taken on an empty stomach. Taking it with food may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include vomiting, decreased potassium level in blood, edema (swelling), decreased white blood cell count, and fatigue. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Other than this, yellowing of skin, loss of appetite, shortness of breath, dark urine and nausea can happen, which indicate some liver problem. Your doctor might check you for liver function, blood pressure, and the level of potassium in your blood.
Before taking it, tell your doctor if have high blood pressure, heart problem, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It may harm your baby. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You may be asked for regular monitoring of blood glucose level while on treatment.
Additional Information:
Product Details:
| Strength | 400 mg/16 ml |
| Brand | Abevmy 400mg Injection |
| MANUFACURE | MYLAN PHARMACEUTICALS PVT LTD |
| Composition | Each vial contains 400 mg of Bevacizumab |
| Treatment | Metastatic colorectal cancer THERAPEUTIC GOODS ADMINISTRATION Non-squamous non-small cell lung canc |
Abevmy 400mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Abevmy 400mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.
Abevmy 400mg Injection is often administered as a combination with other chemotherapy agents. Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Abevmy 400mg Injection. Before starting treatment with this medicine, let your doctor know if you have high blood pressure, high blood sugar, stomach disorders, or heart problems. This medicine should not be taken for 28 days before and after surgery as it is associated with poor wound healing and high bleeding complications. It is advised to report to your doctor if you have any dental issues that require surgery before taking this medicine. In case you develop any visual changes or confusion, report to your doctor to prevent complications.
Product Details:
| Strength | 150iu |
| Packaging Size | 1 injection |
| Packaging Type | Vial |
| Composition | Menotrophin (150i.u) |
| Marketed by | Emcure Pharmaceuticals Ltd |
Product Details:
| Strength | 100 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Dasatib |
| Marketed by | Samarth Life Sciences Pvt Ltd |
| Coposition | Dasatinib (100mg) |
Product Details:
| Strength | 4 mg |
| Brand Name | Zoldonat, Reclast, Zometa |
| Composition | Zoledronic Acid (4mg) |
| Manufacturer | NATCO PHARMA LTD |
| Treatment | Osteoporosis, Paget's disease, bone metastases, hypercalcemia of malignancy |
Product Name: Zoldonat 4mg Injection
Brand Name: Zoldonat, Reclast, Zometa
Composition: Zoledronic Acid (4mg)
Manufacturer/Marketer: NATCO PHARMA LTD
Packaging: To be provided (specify packaging details if available)
Treatment: Osteoporosis, Paget's disease, bone metastases, hypercalcemia of malignancy
Product Description: Zoldonat 4mg Injection contains Zoledronic Acid, a bisphosphonate used for the treatment of osteoporosis, Paget's disease, and to manage bone metastases and hypercalcemia caused by malignancies. It works by slowing bone resorption, improving bone density, and reducing the risk of fractures